Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
Pediatric atopic dermatitis associated with chronic school absenteeism
Children with atopic dermatitis, but not those with psoriasis, were likely to be absent from school at least 15 days a year due to their condition, according to a study.
Q&A: Treating pediatric scars a team effort
Scars — whether from burns, injuries or other causes — can impact an individual’s life in many ways, and oftentimes these physical marks first appear in childhood.
Log in or Sign up for Free to view tailored content for your specialty!
Severe atopic dermatitis associated with depression, internalizing behaviors in children
Severe atopic dermatitis is associated with depression and internalizing behaviors in childhood and adolescence, according to a study.
Abrocitinib effective, well tolerated in adolescent atopic dermatitis
Oral abrocitinib, in combination with topical therapy, was effective and well tolerated in the treatment of moderate to severe atopic dermatitis in adolescents, according to phase 3 study results.
Increased hidradenitis suppurativa education needed to aid pediatric diagnosis, treatment
Greater training in hidradenitis suppurativa diagnosis and treatment in pediatric patients could lead to more effective management and fewer high-cost emergency department visits, according to a retrospective cohort study.
Spinosad 0.9% efficacious in scabies treatment
Topical spinosad was effective in eradicating scabies with a single treatment, according to two clinical studies.
St. Jude registry identifies melanoma subgroups, assists in treatment choices
A pediatric melanoma registry developed at St. Jude Children’s Research Hospital has helped researchers improve the classification of pediatric melanocytic tumors.
Consider age, available space in pediatric allergic contact dermatitis patch testing
Practitioners should take patient age, available space for the patch and allergy frequency into consideration when determining the best option for pediatric patch testing for allergies, according to a research letter.
FDA approves Dalvance for pediatric ABSSSI treatment
The FDA approved the AbbVie’s Dalvance (dalbavancin) for the treatment of acute bacterial skin and skin structure infections in pediatric patients from birth, according to a press release.
Infantile hemangiomas at multiple sites may increase PHACE syndrome risk
Facial infantile hemangiomas at multiple sites may put infants at risk for posterior fossa malformations, hemangiomas, arterial anomalies, cardiac defects and eye anomalies, known as PHACE syndrome, according to a study.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read